HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

9th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain
Infection 2025

The characterization of a rhamnosilated triterpenic saponin from Quillaja saponaria Mol. reveals novel adjuvant, antibacterial, antiviral and antifungal properties

Speaker at Infectious Diseases Conference - Roberto Bobadilla Fazzini
Desert King, Chile
Title : The characterization of a rhamnosilated triterpenic saponin from Quillaja saponaria Mol. reveals novel adjuvant, antibacterial, antiviral and antifungal properties

Abstract:

Quillaja is a rich source of triterpenic saponins known for their notable biological activities. In this study, we report the isolation, chemical characterization, and key biological properties of a novel saponin fraction designated as FR, which differs from traditional Quillaja saponins. Fraction FR primarily consists of a unique bidesmosidic glycoside of quillaic acid characterized by LC-MS/MS. It exhibits significant in vitro antibacterial, antifungal, and antiviral activities, as well as in vivo immunostimulant effects. These findings expand the potential applications of Quillaja saponins, particularly as vaccine adjuvants and antimicrobial or antiviral agents with promising clinical relevance.

Biography:

Dr. Roberto Bobadilla studied Biochemistry at the Pontificia Universidad Catolica de Chile graduated as MS in 1998, and got his PhD degree in 2006 working at the German Research Center of Biotechnology (currently the Helmholtz Centre for Infectious Research). He has more than 15 years experience in the industrial sector with international patents granted in several countries including US, Europe, China and Japan. In 2021 joined Desert King, a leading company with offices in US, Chile and Mexico, focused on innovative natural ingredient solutions for the pharmaceutical industry.

Watsapp